Evidence Analysis

It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.

Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:

  • Does the technology improve health outcomes?
  • Are there other benefits associated with the technology?
  • What harms might be associated with the technology?
  • Have patient selection criteria been established for the technology?
  • For which patients might the technology provide a benefit?

LiverMultiScan (Perspectum) for Diagnosis of Liver Fibrosis and Steatosis Related to Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Focus of the Report: This Health Technology Assessment focuses on evaluating the effectiveness and safety of the LiverMultiScan compared with other imaging and blood marker tests for assessment of liver fibrosis or steatosis in patients who have known or suspected non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NAS…

read more

OPRA Implant System (Integrum Inc.) in Patients With Transfemoral Amputation

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support use of the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System (Integrum Inc.) for the restoration of function in patients who are unable to use or report complications that result from conventional socket…

read more